← Back to headlines
Biotech Stock Surges Over 1,000% Since July, Jefferies Predicts Further Gains
A clinical-stage biotechnology stock has seen a dramatic increase of over 1,000% since late July, with Jefferies initiating coverage at a buy rating and anticipating additional gains.
16 Mar, 11:02 — 16 Mar, 11:02
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
P5,000 aid brings relief to 2,959 Tagbilaran tricycle drivers
just now
Cagayan de Oro Transport Workers Receive Fuel Price Aid
just now
Philippines No Longer Southeast Asia's Worst for Fuel Price Hikes, Economic Pain Persists
just now